Nektar Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '25 Dec 10, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	898	137	85	353	1,841	2,234	Upgrade
Market Cap Growth	507.62%	61.93%	-76.00%	-80.86%	-17.57%	-22.09%	Upgrade
Enterprise Value	821	103	-16	148	1,378	1,550	Upgrade
Last Close Price	43.51	10.98	6.64	27.51	151.88	184.73	Upgrade
PS Ratio	19.28	1.74	1.20	4.61	24.47	19.94	Upgrade
PB Ratio	14.19	2.82	0.82	1.16	3.67	2.83	Upgrade
P/TBV Ratio	14.19	2.82	0.82	1.46	4.14	3.05	Upgrade
EV/Sales Ratio	17.45	1.31	-	1.94	18.31	13.84	Upgrade
EV/FCF Ratio	-5.79	-	-	-	-	-	Upgrade
Debt / Equity Ratio	1.96	3.20	1.76	0.78	0.50	0.33	Upgrade
Asset Turnover	0.21	0.28	0.16	0.10	0.08	0.09	Upgrade
Inventory Turnover	-	-	1.91	1.24	1.60	1.39	Upgrade
Quick Ratio	4.09	4.18	5.97	7.53	8.90	9.55	Upgrade
Current Ratio	4.24	4.26	6.45	8.01	9.34	9.83	Upgrade
Return on Equity (ROE)	-180.24%	-124.10%	-110.95%	-70.39%	-59.64%	-35.80%	Upgrade
Return on Assets (ROA)	-27.98%	-23.14%	-15.25%	-16.43%	-21.00%	-13.51%	Upgrade
Return on Capital (ROIC)	-33.61%	-26.34%	-16.66%	-17.96%	-22.80%	-14.33%	Upgrade
Return on Capital Employed (ROCE)	-58.00%	-53.60%	-39.00%	-37.40%	-43.20%	-26.70%	Upgrade
Earnings Yield	-10.00%	-69.35%	-256.12%	-86.68%	-21.01%	-14.57%	Upgrade
FCF Yield	-15.77%	-103.28%	-179.50%	-72.91%	-17.15%	-10.51%	Upgrade
Buyback Yield / Dilution	-14.07%	-8.24%	-1.53%	-2.10%	-2.64%	-2.05%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.